These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25544304)

  • 1. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
    Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
    J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Propranolol for the Treatment of Infantile Hemangiomas in the Post-Proliferative Phase: A-Single Center Retrospective Study of 31 Cases.
    Tian Y; Xu DP; Tong S; Xi SL; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Aug; 74(8):1623-9. PubMed ID: 27055227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large Doses of Propranolol for the Treatment of Infantile Cephalic and Facial Hemangiomas: A Clinical Report of 38 Cases.
    Jianguo K; Xichun W; Mingkun Z; Qiaoling C; Wenjin L
    J Clin Pediatr Dent; 2015; 39(3):268-71. PubMed ID: 26208073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and blood glucose parameters in infants during propranolol initiation for treatment of symptomatic infantile hemangiomas.
    Puttgen KB; Summerer B; Schneider J; Cohen BA; Boss EF; Bauman NM
    Ann Otol Rhinol Laryngol; 2013 Sep; 122(9):550-4. PubMed ID: 24224397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
    Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
    Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
    Liu LS; Sokoloff D; Antaya RJ
    Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
    Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
    Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of intralesional propranolol in infantile hemangiomas.
    Torres-Pradilla M; Baselga E
    Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment.
    Petrovic J; Trifunovic B; Vukomanovic G; Topalovic M; Trajkovic G; Parezanović V
    J Dermatolog Treat; 2017 Sep; 28(6):554-558. PubMed ID: 28043186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerance of propranolol in neonates with severe infantile hemangiomas: a prospective study.
    Ji Y; Chen S; Xiang B; Yang Y; Qiu L
    Sci Rep; 2017 May; 7(1):1503. PubMed ID: 28473717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of superficial infantile hemangiomas with topical propranolol].
    Niu JN; Xu GQ; Lü RR; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of infantile parotid hemangioma with propranolol].
    Liu XJ; Qin ZP; Tai MZ; Li KL; Ge CX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):292-4. PubMed ID: 20654246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol for problematic head and neck hemangiomas: an analysis of 37 consecutive patients.
    Lv MM; Fan XD; Su LX
    Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):574-8. PubMed ID: 22326207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Propranolol in the treatment of problematic infantile hemangiomas].
    Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
    Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
    Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.